COH
Cochlear
Cochlear is a leading global provider of implantable hearing solutions, known for its innovative cochlear implant systems. The company holds a strong market position due to its advanced technology and commitment to improving hearing outcomes. Cochlear's unique value lies in its continuous investment in research and development, ensuring cutting-edge solutions for hearing loss.
Shorted
About
website
industry
address
Key Metrics
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Short Position Trends
Track bearish sentiment and short interest over time
Historical Price Data
View stock price movements, volume, and trading patterns
Industry & Focus
Company Overview
AI-generated company summary
Cochlear is a leading global provider of implantable hearing solutions, known for its innovative cochlear implant systems. The company holds a strong market position due to its advanced technology and commitment to improving hearing outcomes. Cochlear's unique value lies in its continuous investment in research and development, ensuring cutting-edge solutions for hearing loss.
Company History
Cochlear was founded in 1981, following the pioneering work of Dr. Graeme Clark in developing the first multi-channel cochlear implant. Over the years, the company has expanded its product offerings and global presence, becoming a leader in implantable hearing solutions. Major milestones include the launch of the Nucleus® cochlear implant system and the development of the world's first smart cochlear implant system.
Competitive Advantages
Cochlear's competitive advantages include its strong brand reputation, extensive global distribution network, and continuous innovation in hearing technology. The company's focus on research and development ensures it remains at the forefront of the industry.
Risk Factors
- •Regulatory changes affecting medical devices
- •Competition from other hearing solution providers
- •Potential product recalls or failures
Recent Developments
Last 6 months
Cochlear has recently focused on expanding its product line with the introduction of the Nucleus® Kanso® 3 Sound Processor, enhancing connectivity and user experience.
Key People
Leadership team at Cochlear
Dig Howitt
CEO
Dig Howitt has been the CEO of Cochlear since 2018, leading the company with a focus on innovation and global expansion.
Stuart Sayers
CFO
Stuart Sayers joined Cochlear as CFO, bringing extensive experience in financial management and strategic planning.